GENEVAD, SE / / March 19, 2026 / MindMaze Therapeutics Holding SA (SIX: MMTX ) (the Company), a global leader in brain technology and precision neurotherapeutics, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results